Regranex Gel 0.01%
NDC 85822-734, Becaplermin gel 0.01%, gel, from LRM Therapeutics, LLC.
- Product NDC
- 85822-734
- Status
- Listed
- Labeler
- LRM Therapeutics, LLC
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103691
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85822-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BECAPLERMIN.1 mg/g
Pharmacologic classes
Human Platelet-derived Growth Factor [EPC]; Platelet-Derived Growth Factor [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85822-734-15 | 85822073415 | 15 g in 1 TUBE (85822-734-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/377b3021-13d7-96d5-e063-6394a90a8ca3
Use it
Look up 85822-734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85822-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85822-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.